GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.90% | -152.34% | |||
| Total Other Revenue | 7.83% | -45.54% | |||
| Total Revenue | 7.51% | -94.71% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 7.51% | -94.71% | |||
| SG&A Expenses | 7.85% | -21.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.85% | -27.47% | |||
| Operating Income | -7.85% | 20.30% | |||
| Income Before Tax | -7.85% | 15.36% | |||
| Income Tax Expenses | -8.51% | -155.29% | |||
| Earnings from Continuing Operations | -7.85% | 15.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.85% | 15.64% | |||
| EBIT | -7.85% | 20.30% | |||
| EBITDA | -7.85% | 20.31% | |||
| EPS Basic | -7.69% | 28.50% | |||
| Normalized Basic EPS | -7.82% | 28.11% | |||
| EPS Diluted | -7.69% | 28.50% | |||
| Normalized Diluted EPS | -7.82% | 28.11% | |||
| Average Basic Shares Outstanding | 0.00% | 17.94% | |||
| Average Diluted Shares Outstanding | 0.00% | 17.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||